Skin Reactions Related to Thoracic Implantable Chamber Dressings
Recruiting
Observational Study
Skin Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Institut Curie · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Prospective, multicenter cohort of 500 patients newly treated with systemic chemotherapy with CCI. The main objective of this study is to measure the incidence of skin reactions related to thoracic implantable chamber dressings.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients over 18 years of age
* New chemotherapy patients (1st line of treatment only)
* Thoracic PAC
Exclusion Criteria:
* PICC Line and femoral PAC;
* Patients undergoing treatment with bi-specific antibodies (e.g. tebentafusp);
* Disunion requiring treatment
* Patients tr…
Contacts